MoghanakiD.; MickR.; FurthE.; SohalD.; SalmonP.; BehbahaniA.; MorgansA.; MillerS.; GiantonioB.; WhittingtonR.; HallerD.; RosatoE.; PlastarasJ. Resection Status, Age and Nodal Involvement Determine Survival among Patients Receiving Adjuvant Chemoradiotherapy in Pancreatic Adenocarcinoma. JOP. Journal of the Pancreas, v. 12, n. 5, p. 438-444, 10 ago. 2011.